「ios」の検索結果

Manual for the marginaleffects R and Python package, and guide to the book "Model to Meaning". Use when users ask about predictions, comparisons, slopes, marginal effects, average treatment effects (ATE/ATT/CATE), hypothesis testing, contrasts, counterfactuals, risk ratios, odds ratios, causal inference with G-computation, or need help with marginaleffects functions like predictions(), comparisons(), slopes(), hypotheses(), datagrid(), avg_predictions(), avg_comparisons(), avg_slopes(), or plot functions.

日本語の概要は準備中です。原文の説明を表示しています。

Stop coding agents from shipping generic UI. Use UIZZE's 800,000+ real web and iOS screens to build product-specific interfaces, define a design contract, cover required states, and run a hard finish gate. Use for web or iOS UI design, implementation, redesign, critique, and pre-ship review in Codex, Claude Code, Cursor, Copilot, and other coding agents.

日本語の概要は準備中です。原文の説明を表示しています。

Calibrate a new dataset from live RTSP camera streams via the AutoMagicCalib REST API. Use when the user provides RTSP URLs or asks to calibrate live cameras; VIOS records clips, AMC ingests them, then runs calibration.

日本語の概要は準備中です。原文の説明を表示しています。

[omh] Releasing an iOS or Android app through the stores -- signing, the privacy manifest, a TestFlight or Play beta, a staged rollout, a hotfix: prepare each gate the store enforces, and plan the halt and the next build before the rollout starts, because a store release cannot be rolled back. Use when the user says: mobile-release, mobile release, mobile app release, ios release, android release, app store release, app store submission, submit to the app store.

日本語の概要は準備中です。原文の説明を表示しています。

[omh] Designing or reviewing an iOS, macOS, or Apple-style UI: prepare native Apple UI or Apple marketing product-visual direction, review, and improvement briefs with evidence-backed remediation handoffs. Use when the user says: apple-design, apple design, apple ui design, apple hig, human interface guidelines, ios design guidelines, macos app design, apple-inspired web.

日本語の概要は準備中です。原文の説明を表示しています。

Monitor dividend portfolios with Kanchi-style forced-review triggers (T1-T5) and convert anomalies into OK/WARN/REVIEW states without auto-selling. Use when users ask for 減配検知, 8-Kガバナンス監視, 配当安全性モニタリング, REVIEWキュー自動化, or periodic dividend risk checks.

Migrate workloads from Heroku to AWS. Triggers on: migrate from Heroku, Heroku to AWS, move off Heroku, migrate Heroku Postgres to RDS, migrate Heroku Redis to ElastiCache, migrate Heroku Kafka to MSK, migrate dynos to Elastic Beanstalk, migrate dynos to Fargate, migrate Heroku Private Space, Heroku to ECS, leave Heroku, what-if workshop, compare migration scenarios, workshop mode. Runs a 6-phase process: discover Heroku resources live via the authenticated Heroku CLI (read-only, consent-gated) and/or from Terraform, Procfile/app.json, and billing exports, then clarify, design, estimate costs, generate artifacts, and collect feedback. Clarify must finish before Design, Estimate, or Generate. An optional post-Estimate what-if workshop reprices region/HA/compute/Graviton scenarios. Do not use for: GCP migrations (see gcp-to-aws), Azure migrations (see azure-to-aws), AWS-to-Heroku reverse migration, general AWS architecture advice without migration intent, or Heroku-to-Heroku refactoring.

日本語の概要は準備中です。原文の説明を表示しています。

Add an iOS App Clip target to an Expo app. Use when the user mentions App Clip, AASA, apple-app-site-association, appclips, smart app banner, or wants to ship a lightweight iOS Clip invoked from a URL alongside their parent app.

日本語の概要は準備中です。原文の説明を表示しています。

Build native UI with the @expo/ui package: real SwiftUI on iOS and Jetpack Compose on Android. Default to @expo/ui for sheets (BottomSheet), pickers, sliders, toggles, menus, and grouped-form sections — do NOT reach for Reanimated, @gorhom/bottom-sheet, or RN built-in Picker/Switch; use @expo/ui instead. Fall back to RN built-ins only when @expo/ui is missing the component. NOTE: @expo/ui List renders native grouped rows like an iOS Settings screen — it is NOT a virtualized list; use FlatList/FlashList for large datasets. Covers universal components (Host, Column, Row, Button, Text, List, BottomSheet, FieldGroup, Switch, Slider, Picker, Menu), drop-in replacements for RN community libraries, and platform-specific SwiftUI/Jetpack Compose trees. Not for Expo Router navigation, Reanimated, or data fetching.

日本語の概要は準備中です。原文の説明を表示しています。

Apply foundational design principles: affordances, signifiers, constraints, feedback, and conceptual models. Use when the user mentions "why is this confusing", "affordance", "error prevention", "discoverability", "human-centered design", "mental model", "mapping", "seven stages of action", "users keep making mistakes", "this is unintuitive", or "people cant figure out how to use it". Also trigger when reducing product complexity or feature creep. Covers the gulfs of execution and evaluation. For usability scoring, see ux-heuristics. For iOS-specific patterns, see ios-hig-design.

日本語の概要は準備中です。原文の説明を表示しています。

Generate NIH Biosketch documents compliant with the 2022 OMB-approved.

日本語の概要は準備中です。原文の説明を表示しています。

Use when someone asks to link a project, file, folder, or important context into AGENTS.md or their AIOS routing, or says "link this into my AIOS" or "add this to my routing".

日本語の概要は準備中です。原文の説明を表示しています。

Use on Day 1 of an AIS-OS install, when someone says "set me up", "onboard me", "let's get started", "fill in my AIOS", or has just cloned the kit. Combined wizard — runs the 7-question intake AND scaffolds the Day-1 file set at the end. Idempotent — re-run any time after editing aios-intake.md.

日本語の概要は準備中です。原文の説明を表示しています。

Builds and ships iOS/macOS apps with XcodeGen, SwiftUI and SPM: Xcode build fixes, device deployment, Apple Developer signing/notarization, CI/CD pipelines. Use for XcodeGen project.yml setup, "Library not loaded @rpath" crashes, code-signing errors (Error -25294, adhoc fallback), or Electron notarization failures. Not for TCC permission dialogs (use macos-permissions) or disk cleanup (use macos-cleaner).

日本語の概要は準備中です。原文の説明を表示しています。

Assess physical and transition climate risk for a site, product, or portfolio with scenario-based structure. Use when asked to run a climate risk assessment, evaluate physical or transition risk, prepare TCFD/ESRS-style climate risk analysis, or assess how climate scenarios affect an asset or business. Produces a hazard-exposure-vulnerability matrix across 2030/2040/2050 horizons and labelled scenarios, with financial-impact ranges, confidence levels, and adaptation options.

日本語の概要は準備中です。原文の説明を表示しています。

Detect business logic vulnerabilities in a codebase using a three-phase approach: threat modeling (domain analysis and attack scenarios), batched verify (check exploitable gaps in parallel subagents, 3 scenarios each), and merge (consolidate batch results). Covers price manipulation, workflow bypass, limit violations, race conditions, reward abuse, etc. Requires sast/architecture.md (run sast-analysis first). Outputs findings to sast/businesslogic-results.md. Use when asked to find business logic, logic flaws, or abuse-of-function bugs.

日本語の概要は準備中です。原文の説明を表示しています。

Render a static iOS QWERTY keyboard as inline HTML+CSS sized for the 750-wide 9:16 stage. Includes the 3-suggestion bar, alpha keys, shift/backspace, 123/emoji/space/return row, and the bottom globe+mic strip. No animation logic — slide up/down is the molecule's job (CSS transform on the .keyboard root).

日本語の概要は準備中です。原文の説明を表示しています。

Extracts cfDNA fragmentomics features (DELFI genome-wide short/long ratios, WPS nucleosome positioning, Griffin GC-corrected accessibility profiles, end-motifs/MDS, OCF) for cancer detection and tissue-of-origin from plasma WGS. Centers on the nuclease-footprint reframe (every feature re-reads one nucleosome object), the mandatory GC correction, and the cross-protocol non-comparability that breaks naive classifiers. Runs FinaleToolkit (real CLI/Python, MIT) and the Griffin Snakemake pipeline; DELFI is a method, not a package. Use when deriving fragment-based signal from cfDNA, choosing a feature family for detection vs subtyping, or diagnosing why a fragmentomic model failed validation.

日本語の概要は準備中です。原文の説明を表示しています。

Structures biological experiments so inference is valid by construction, covering Fisher's principles (randomization, replication, local control), the experimental-vs-observational unit distinction and pseudoreplication (Hurlbert 1984; Lazic 2018), randomization mechanics (complete, restricted, stratified, rerandomization, run-order), blocking layouts (randomized complete block, Latin square, incomplete block), factorial designs and interactions, and the split-plot/nested error strata hidden inside multi-batch genomics. Use when deciding the experimental unit and what counts as a replicate, planning randomization and run order, choosing a blocked/factorial/split-plot/nested layout, avoiding pseudoreplication in cell-culture or animal studies, or specifying the random-effects structure of the analysis model. For assigning samples to sequencing batches/lanes/plates and batch-effect correction see experimental-design/batch-design; for regulated clinical-trial randomization see clinical-biostatistics.

日本語の概要は準備中です。原文の説明を表示しています。

Estimates the minimum biological replicates (or cells/events) for a target power at a target FDR in genomics experiments using ssizeRNA, PROPER, powsimR for scRNA-seq, and pilot-data dispersion estimation from DESeq2/edgeR. Covers the biological-versus-technical replication distinction (technical replicates do not add degrees of freedom for biological inference), replicate-number-versus-sequencing-depth budgeting, scRNA-seq sample-versus-cell allocation under a pseudobulk model, and the critique that "n=3" is a publication convention rather than a power calculation. Use when budgeting a sequencing experiment, writing the sample-size justification in a grant, estimating replicates from pilot data, allocating a fixed budget between samples and depth, or planning scRNA-seq cohort size. For clinical-trial sample size see clinical-biostatistics/power-and-sample-size; for the power-given-n direction see experimental-design/power-analysis.

日本語の概要は準備中です。原文の説明を表示しています。

Controls error rates across thousands of simultaneous tests in genomics discovery using false-discovery-rate methods (Benjamini-Hochberg 1995; Benjamini-Yekutieli 2001 for arbitrary dependence; Storey q-value with pi0 estimation; local FDR; independent filtering Bourgon 2010; covariate-weighted FDR via IHW Ignatiadis 2016), plus family-wise error control (Bonferroni, Holm) and the GWAS genome-wide threshold. Covers the FDR-versus-FWER choice as the discovery-versus-confirmatory distinction, the dependence assumptions behind BH (PRDS) versus BY, pi0 estimation, the independent-filtering and false-coverage-rate traps, and reproducibility ranking via IDR (Li 2011). Use when correcting p-values from genome-wide tests, choosing between BH/BY/q-value/Bonferroni, setting an FDR threshold, applying IHW or independent filtering, or interpreting q-values. For confirmatory trials with few pre-specified endpoints (closed testing, graphical/gatekeeping), see clinical-biostatistics/multiplicity-graphical.

日本語の概要は準備中です。原文の説明を表示しています。

Normalizes and transforms RNA-seq count matrices for DE, visualization, clustering, and ML. Covers between-sample (TMM, TMMwsp, RLE/median-of-ratios, upper quartile), within-sample (TPM, FPKM/RPKM), variance-stabilizing (VST, rlog, log-CPM), GC-content correction (cqn, EDASeq), and single-cell (scran deconvolution, scanpy normalize_total). Encodes the composition-bias rationale, the "most genes not DE" assumption and its catastrophic failure modes (MYC amplification, apoptosis, viral host shutoff, prokaryotic stress), the "lengthScaledTPM is not TPM" naming trap, the "TPM is not for DE" rule, the blind=TRUE vs FALSE decision, ERCC spike-in normalization (SBN), and the single-cell zero-inflation breakdown of TMM/RLE. Use when choosing or applying normalization, debugging shifted-MA-plot diagnostics, handling zero-heavy single-cell data, or correcting GC bias.

日本語の概要は準備中です。原文の説明を表示しています。

Calculates statistical power for high-dimensional genomics experiments (bulk RNA-seq, scRNA-seq, ATAC-seq, ChIP-seq, methylation, proteomics) under negative-binomial count models using RNASeqPower, PROPER, and simulation via powsimR, distinguishing per-gene from marginal (transcriptome-wide) power, the role of mean expression and dispersion, and the sequencing-depth-versus-replicate tradeoff. Covers simulation as the honest default for overdispersed counts, FDR-aware average power versus single-test power, observed/post-hoc power as an anti-pattern, and the winner's-curse / Type-S / Type-M consequences of underpowering. Use when planning replicate number for a sequencing experiment, deciding whether to add depth or samples, choosing closed-form versus simulation power, estimating power from pilot dispersions, or justifying replication in a grant. For clinical-trial power see clinical-biostatistics/power-and-sample-size; for the inverse sample-size question see experimental-design/sample-size.

日本語の概要は準備中です。原文の説明を表示しています。

Call copy number variants with the GATK best-practices workflows — the somatic CNV pipeline (CollectReadCounts, DenoiseReadCounts with tangent normalization, ModelSegments, CallCopyRatioSegments) and the germline GATK-gCNV pipeline (DetermineGermlineContigPloidy, GermlineCNVCaller cohort/case mode, PostprocessGermlineCNVCalls). Covers panel-of-normals construction, AnnotateIntervals/FilterIntervals, allelic-count integration, and QS-based filtering. Use when integrating CNV calling into a GATK variant pipeline, calling rare germline CNVs from an exome cohort, deciding between the somatic and germline GATK workflows, or diagnosing why tangent normalization removed a real event or why gCNV output has low precision.

日本語の概要は準備中です。原文の説明を表示しています。